Key statistics
On Monday, Purple Biotech Ltd (1YI:DEU) closed at 6.00, 10.29% above the 52 week low of 5.44 set on Jul 08, 2024.
52-week range
Open | 6.00 |
---|---|
High | 6.00 |
Low | 6.00 |
Bid | 6.00 |
Offer | 6.30 |
Previous close | 6.00 |
Average volume | 55.13 |
---|---|
Shares outstanding | 1.65m |
Free float | 1.64m |
P/E (TTM) | -- |
Market cap | 9.60m USD |
EPS (TTM) | -234.17 USD |
Data delayed at least 15 minutes, as of Sep 23 2024.
More ▼
Announcements
- Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24
- Purple Biotech to Present Data for its Lead Oncology Drug CM24 at the AACR Special Conference on Advances in Pancreatic Cancer Research
- Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference
- Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule
- Purple Biotech to Host Virtual KOL Event to Discuss Positive Interim Results from Phase 2 Pancreatic Cancer Study with CM24 on July 11, 2024
- Purple Biotech Announces Closing of Exercise of Warrants for $2 Million Gross Proceeds
- Purple Biotech Announces Exercise of Warrants for $2 Million Gross Proceeds
- Purple Biotech Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Cancer Study with CM24 Regarding a Potential Predictive Biomarker for Overall Survival Benefit
- Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer
- Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
More ▼